Position Your Solutions as Essential: Become the Go-To Partner for mRNA Leaders Driving the Future of Scalable, Compliant mRNA Therapeutics & Vaccines
As global investment surged across saRNA, circRNA, personalized cancer vaccines, and gene editing, the mRNA field continued its rapid evolution in 2025. With growing clinical and commercial demands, companies faced mounting pressure to deliver robust, scalable, and regulatory-ready platforms.
Throughout the 4th mRNA Process Development & CMC Summit, process development and CMC leaders reaffirmed a critical message: mRNA production cannot succeed without trusted partners. In response, the agenda shaped by industry experts featured dedicated discussions on selecting the right collaborators, technologies, and service providers to drive forward innovation and efficiency.
Held in Boston this September, the summit proved to be the flagship gathering for over 175 mRNA developers focused on overcoming technical bottlenecks, enhancing process efficiency, and securing regulatory approvals. With active participation from Moderna, Sanofi, BioNTech, CureVac, AstraZeneca, GSK, CSL, CEPI, and US Pharmacopeia, the event offered direct access to senior decision-makers across CMC, MS&T, QA/QC, regulatory, and manufacturing functions. It cemented its role as an essential platform for collaboration and progress in mRNA therapeutics.
If You Have Services In:
Then this is your opportunity to stand out in front of hyper-relevant buyers who are actively refining their platforms, building next-gen mRNA programs, and accelerating safe, compliant mRNA therapies to patients.
Partner and:
Leverage Unfiltered Market Intelligence
Hear directly from senior CMC, MS&T, and QA/QC leaders from Moderna, BioNTech, Sanofi, AstraZeneca, CureVac, and more as they reveal where gaps remain across DNA sourcing, IVT, analytics, purification, and regulatory readiness - allowing you to position your solution exactly where the need is greatest.
Showcase High-Impact Technical Solutions
Whether you provide enzymes, LNPs, in-line analytics, digital twins, lyophilization tech, or regulatory strategy consulting, this summit puts your offering in front of hyper-relevant, decision-makers responsible for vendor selection in clinical and commercial-scale mRNA programs.
Engage Buyers at Their Moment of Need
Each session is built around solving a high-priority bottleneck, from dsRNA removal to platform comparability. You’ll know exactly who’s in the room and can use our structured networking tools to forge targeted, high-value commercial connections that drive client growth.
In 2024, Sponsors Networked With:
